background
banner

SIPRO 750 Price

Active Substance: Ciprofloxacin.

57
UAD , based on 7541 reviews.
View Drug details

Overview

Welcome to Dwaey, specifically on SIPRO 750 Tablets/Film-coated page.
This medicine contains an important and useful components, as it consists of Ciprofloxacin.
SIPRO 750 is available in the market in concentration 750mg/Tablet and in the form of Tablets/Film-coated.

ASIA PHARMACEUTICAL INDUSTRIES is the producer of SIPRO 750 and it is imported from SYRIA, The most popular alternatives of SIPRO 750 are listed downward .

Mode Of Action

Ciprofloxacin promotes breakage of double-stranded DNA in susceptible organisms and inhibits DNA gyrase, which is essential in reproduction of bacterial DNA.

Indication

  • Cystic fibrosis
  • Intra-abdominal infections
  • Meningitis
  • Peritonitis
  • Endocarditis
  • Anthrax
  • Otitis media
  • Septicaemia
  • Lower Respiratory Tract Infections
  • Cystitis
  • Gonorrhoea
  • Skin and skin structure infections
  • Nosocomial pneumonia
  • Urinary tract infections
  • Enteric fever
  • Bone and Joint Infections
  • Biliary tract infections
  • Surgical Prophylaxis
  • Gastroenteritis
  • Q fever
  • Acute Sinusitis
  • Cat scratch disease
  • Spotted fever
  • Typhus
  • Chanroid
  • Brucellosis
  • Typhoid and paratyphoid fever
  • Superficial ophthalmic infections
  • Otitis externa

Precaution

Epilepsy, history of CNS disorders; severe renal or hepatic dysfunction; G6PD deficiency; maintain adequate hydration; myasthaenia gravis. Caution when used in patients with QT prolongation or risk factors e.g. bradycardia, pre-existing cardiac disease or uncorrected electrolyte disturbances. Discontinue treatment if patients experience tendon pain, inflammation or rupture. Avoid usage in methicillin-resistant staphylococcus aureus (MRSA) infections due to high level of resistance. May impair ability to drive or operate machinery. Safety and efficacy have not been established in pregnant and lactating women. Not to be used in children <18 yr; except where benefit clearly exceeds risk. Lactation: Drug enters breast milk; use not recommended (American Academy of Pediatrics Committee states that drug is compatible with nursing)

Side Effects

  • 1-10% Nausea (3%)
  • Abdominal pain (2%)
  • Diarrhea (2% adults; 5% children)
  • Increased aminotransferase levels (2%)
  • Vomiting (1% adults; 5% children)
  • Headache (1%)
  • Increased serum creatinine (1%)
  • Rash (2%)
  • Restlessness (1%) <1% Acidosis
  • Allergic reaction
  • Angina pectoris
  • Anorexia
  • Arthralgia
  • Ataxia
  • Back pain
  • Bad taste
  • Blurred vision
  • Breast pain
  • Bronchospasm
  • Diplopia
  • Dizziness
  • Drowsiness
  • Dysphagia
  • Dyspnea
  • Flushing
  • Foot pain
  • Hallucinations
  • Hiccups
  • Hypertension
  • Hypotension
  • Insomnia
  • Irritability
  • Joint stiffness
  • Lethargy
  • Migraine
  • Nephritis
  • Nightmares
  • Oral candidiasis
  • Palpitation
  • Photosensitivity
  • Polyuria
  • Syncope
  • Tachycardia
  • Tinnitus
  • Tremor
  • Urinary retention
  • Vaginitis Potentially Fatal: Anaphylactoid reaction; cardiopulmonary arrest.

Contra indication

Hypersensitivity. Not to be used concurrently with tizanidine. Avoid exposure to strong sunlight or sun lamps during treatment.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

May increase plasma concentrations of CYP1A2 substrates (e.g. clozapine, ropinirole, theophylline). Enhances effect of oral anticoagulants (e.g. warfarin) and glibenclamide. Increased toxicity of methotrexate. Plasma concentrations may be increased by probenecid. Reduced absorption w/ oral multivitamins and mineral supplements containing divalent or trivalent cations (e.g. Fe, Zn, Ca) and antacids containing Al, Ca or Mg. Concomitant use w/ class IA antiarrhythmics (e.g. quinidine, procainamide), class III antiarrhythmics (e.g. amiodarone, sotalol), TCAs, macrolides and antipsychotics may result in additive effects on QT interval prolongation. Concurrent use w/ corticosteroids may increase risk of severe tendon disorders. Increased risk of CNS stimulation w/ NSAIDs. Altered serum concentrations of phenytoin. Potentially Fatal: Marked elevation in serum levels of tizanidine which is associated w/ potentiated hypotensive and sedative effect.

Alternatives Price List

  • XAROCEN 400mg/200mlUAD 104
  • XAROCEN 200mg/100mlUAD 52
  • SIPRO 750UAD 57
  • RECIPRO 500mg UAD 31
  • RECIPRO 500mg UAD 302

Releated Products

banner

Report Price Error

Please feel welcome to contact Us with any price or medical error. Our doctors will receive any reports.